Part 1 Basic Information
Name: Xueyong Qi
Address: School of Pharmacy, Jiangsu University, No. 301 Xuefu Road, Zhenjiang, Jiangsu 212013, China
Tel: 0511-85038451
Email: qixyemail@163.com
Part 2 Personal Profile
Xueyong Qi, male, Associate Professor and Master's Supervisor at the School of Pharmacy, Jiangsu University. He has long been engaged in research on pharmaceutical preparations and their quality control, as well as quality evaluation of traditional Chinese medicine. He has previously served as a technician at Zhenjiang Pharmaceutical Co., Ltd., Director of the Department of Pharmaceutics at the School of Pharmacy, Jiangsu University; Deputy Director of the Market Supervision Administration of Gaogang District, Taizhou City, and Deputy Secretary of the Party Committee of Dasi Town, as well as Deputy General Manager of Jiangsu Hengxin Pharmaceutical Co., Ltd. He serves as a peer reviewer for the journal China Cosmetic Science and as a member of its Academic Committee. He is also a Standing Member of the Expert Think Tank Committee of the China Cosmetics Industry-University-Research Collaborative Innovation Platform.
Part 3 Education
•2006.09-2009.12, Zhejiang University, Pharmaceutical Analysis ,Ph.D.
•2001.09-2004.07, China Pharmaceutical University, Pharmaceutical Analysis,M.S.
•1988.09-1992.07, China Pharmaceutical University, Pharmaceutical Analysis,B.S.
Part 4 Work Experience
•1996.06–Present, School of Pharmacy, Jiangsu University, Associate Professor, Master's Supervisor
•2022.07–2024.07, Deputy General Manager of Jiangsu Hengxin Pharmaceutical Co., Ltd. (Jiangsu Provincial Science and Technology Deputy General Manager Program)
• 2017.08–2018.07, Deputy Director of the Market Supervision Administration of Gaogang District, Taizhou City, concurrently Deputy Secretary of the Party Committee of Dasi Town (Jiangsu Provincial Science and Technology Town Mayor Group)
•2014.09–2015.01, Stevens Institute of Technology, USA, Visiting Scholar
•1992.07–1996.06, Zhenjiang Pharmaceutical Factory, Assistant Engineer
Part 5 Research Interests
1.Pharmaceutical preparations and their quality control
2.Quality evaluation of traditional Chinese medicine
3.Quality control of cell therapy medicinal products
Part 6 Research Achievements
6.1 Research Projects
•2026.03–2026.06 | Commissioned/Industry-Sponsored Project | An Antioxidant-Synergistic Exosome and Its Preparation Method (Project No.: HX20260213) | Principal Investigator
•2026.03–2026.06 | Commissioned/Industry-Sponsored Project | A Method for Enhancing the Tumor-Killing Effect of NK Cells and Its Application (Project No.: HX20260214) | Principal Investigator
•2025.08–Present | Commissioned/Industry-Sponsored Project | Development of Plant Extracellular Vesicle Extraction Process (Project No.: HX20250819) | Principal Investigator
•2025.08–Present | Commissioned/Industry-Sponsored Project | Development of Key Technologies for Purification of Brain Protein Hydrolysate Polypeptides (Project No.: HX20250792) | Principal Investigator
•2024.11–Present | Commissioned/Industry-Sponsored Project | Construction of Artemisinin-Loaded ZIF-8 Single-Atom Nanozyme and Its Application in Tumor Therapy Research (Project No.: HX20241099) | Principal Investigator
•2021.04–2023.04 | Commissioned/Industry-Sponsored Project | Study on the Sustained/Controlled-Release Mechanism and Improvement of Pharmaceutical Carbomer (Project No.: HX20210294) | Principal Investigator
•2020.04–2020.12 | Commissioned/Industry-Sponsored Project | Study on Quality Control of Aluminum Salts in Oral Rehydration Salts Powder (III) (Project No.: HX20200111) | Principal Investigator
6.2 Publications
1.Cui Junming, Cai Xinxi, Qian Rui, Wu Lin, Qi Xueyong, Cao Jin, Shen Song.Tween 80 Micelles Loaded with Fe3O4 Nanoparticles and Artemisinin for Combined Oxygen-Independent Ferroptosis Therapy of Cancer[J]. Pharmaceutics, 2024, 16(5): 639
2.Li Zhiye, Qian Chenyao, Zheng Xiaodan, Qi Xueyong, Bi Jingyue, Wang Huan, Cao Jin.Collagen/chitosan/genipin hydrogel loaded with phycocyanin nanoparticles and ND-336 for diabetic wound healing[J]. International Journal of Biological Macromolecules, 2024, 266: 131220
3.Wu Lin, Zhao Kai, Xu Leyuan, Cui Junming, Ruan Li, Bei Shifang, Cao Jin, Qi Xueyong, Shen Song.Macrophages-mediated delivery of protoporphyrin for sonodynamic therapy of rheumatoid arthritis[J]. Ultrasonics Sonochemistry, 2024, 107:
4.Lu Ying, Liu Mengxiao, Yin Yanzhao, Zhao Junsheng, Cao Jin, Qi Xueyong, Wu Lin, Shen Song.Self-Hijacking Ferritin Nanostructures for Targeted Delivery of Iron to Enhance Synergistic Anticancer Therapy[J]. ACS Applied Nano Materials, 2025, 8(20): 10503-10515
5.Qian Chenyao, Wang Huan, Bi Jinyue, Zheng Xiaodan, Li Rujia, Luo Huan, Qi Xueyong, Shen Song, Cao Jin.A biomimetic manganese-phycocyanin nanodrug-carrying system and its sonodynamic-immunological anti-tumor therapy[J]. International Journal of Pharmaceutics, 2025, 677: 125626
6.Song Ge, Qi Xueyong, Zhao Yi.iRGD Tumor Penetrating Peptide-Modified NK Cells Exhibit Enhanced Tumor Immune Infiltration Ability and Anti-Tumor Efficacy[J]. Protein and peptide letters, 2025, 32(3):183-193
7.Wang Huan, Qian Chenyao, Bi Jinyue, Zhou Jin, Li Xinpei, Qi Xueyong, Shen Song, Cao Jin.In situphotothermal-chemical dynamics synergistic enhancement of anti-tumor effect based on phycocyanin multifunctional nanosystem[J]. Colloids and surfaces B, Biointerfaces, 2025, 256(Pt 2): 115018-115018
8.Zheng Xiaodan, Qian Chenyao, Wang Huan, Bi Jinyue, Qi Xueyong, Shen Song, Cao Jin.Phycocyanin- and Polydopamine-Conjugated Titania Nanoparticles for UV Protection[J]. ACS Applied Nano Materials, 2025, 8(14): 6983-6993
9.Dong X., Wang L., Lin S. J., Wang Z. Y., Qi Xueyong., Cao J., Zhang J., Wu L., Shen S.Targeted degradation of xanthine oxidase via PROTAC technology for the treatment of hyperuricaemia[J]. Journal of Materials Chemistry B, 2026, 14(16): 5066-5079
10.Wang H., Lin S. J., Zhou J., Bi J. Y., Wang Y. M., Li X. P., Yang Q., Wu S. Y., Qi Xueyong, Shen S., Cao J.A natural COX-2 inhibitor-integrated nanoplatform for TNBC immunotherapy: Mn-PC-PTX synergizes chemotherapy and immune activation[J]. Colloids and Surfaces B-Biointerfaces, 2026, 265
6.3 Monographs and Textbooks
•Xueyong Qi (Editor-in-Chief). Experiment of Pharmaceutical Analysis. Zhenjiang: Jiangsu University Press, 2018. ISBN 978-7-5684-0884-4, Editor-in-Chief
•Hua He (Editor-in-Chief). Biopharmaceutical Analysis (Second Edition). Beijing: Chemical Industry Press, 2014. ISBN 978-7-122-19003-1, Associate Editor-in-Chief
•Shanshan Tong (Editor-in-Chief). Pharmaceutical Analysis. Zhenjiang: Jiangsu University Press, 2018. ISBN 978-7-5684-0946-9, Contributing Editor
•Yuhui Ping (Editor-in-Chief). Review Guide for Pharmaceutical Analysis. Tianjin: Tianjin Science and Technology Translation & Publishing Co., Ltd., 2014. ISBN 978-7-5433-3310-9, Contributing Editor
6.4 Patents and Software Copyrights
•Xueyong Qi, Xuexue Liu, Song Shen, Lin Wu, Jin Cao. A Magnetic Oxidation-Responsive Drug-Loaded Nanomicelle and Its Preparation Method and Application. ZL 2021 1 0573403.5 [P], 2021-05-25
•Song Shen, Maimaiti Maierhaba, Xueyong Qi, Lin Wu, Jin Cao. A CaO2/Fe3O4@OA Nanocomposite and Its Preparation Method and Application. ZL 2021 1 0240425.X [P], 2021-03-04
•Xiao Xie, Jie Li, Xueyong Qi, Wang Gang. A Method for Detecting 11 Components in Compound Amino Acid Injection [P]. ZL 2022 1 0445842.2, 2024-03-12
•Xiaoyun Yu, Xueyong Qi, Yanru Ge. A Method for Detecting the Effectiveness of Pharmaceutical Services for AIDS Patients. ZL 2022 1 0258533.4 [P], 2024-06-11
•Yijin Wang, Xueyong Qi, Yunfei Lian, Ge Song, Yedi Zhou. A Method for Enhancing the Tumor-Killing Effect of NK Cells and Its Application. ZL 2023 1 0359454.7 [P], 2026-01-02
•Jinqiu Huang, Yunfei Lian, Xueyong Qi, Ge Song, Shiqing Yang. An Antioxidant-Synergistic Exosome and Its Preparation Method. ZL 2023 1 0359459.X [P], 2026-01-02
•Guoquan Li, Bing Lu, Xueyong Qi, Bin Chen, Jie Li, Chengyun Zheng. Tea X-ray Fluorescence Data Analysis Software [Abbreviated as TSTXRD] V1.0. 2019SR0764129. 2019-07-23
